Joseph Seitlinger (@JoSeitlinger) profile picture

Thoracic Surgeon Associate Professor, University hospital Nancy France

Nancy, France
Joined February 2018
Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)Photo by Joseph Seitlinger (@JoSeitlinger)
To any health care institution or headhunter seeking world-class physicians and surgeons, the Quebec legistlature has passed a new special law severly impacting the civil and professional liberties of medical practitioners in our province, where average remuneration was already one of the lowest in North America, in a jursidiction with one of the highest tax rates in the world. You now have the opportunity to recruit top medical talent to your institution! Quebec medical professionals are accustomed to working in a resource limited setting, in high-volume practices for discounted rates. Now's your chance to recruit and you can thank @cdube_sante, @francoislegault and the @coalitionavenir for this health care fire sale!
30
19
8
85
38,831
200+ robotic thoracic surgeries “Out of the Cage” at CHRU Nancy! Less pain, same excellence. 💪🤖 🎯 Milestone achieved at CHRU de Nancy! We’re proud to celebrate over 200 “Out of the Cage” robotic thoracic surgeries. Stephane RENAUD Arhur STREIT Florent STASIAK Moishe LIEBERMAN
2
70
Another inspiring lab meeting with our brilliant students. Very pleased that the Spicer lab can celebrate 10 years of science with continuous funding from various sources. Couldn’t have done it without my research partner @ronirayes who has been there from the beginning and all our students and collaborators along the way. Many thanks to the MGH Foundation/@mcgillsurgery, @SRC_CRS, @CIHR_IRSC, @FRQS1, @AATSHQ, @AmerSurg, @tfri_research, @rossy_cancer, @RIMUHC1, @MThoracics and @McGillGCI
3
7
51
2,578
Please check out this important publication on the Ipi/Nivo arm of CM816. Lots of very interesting findings that may help us better understand the meaning of endpoints and potential for neoadjuvant escalation! ascopubs.org/doi/10.1200/JCO… @AATSHQ @thoracic @ThoracicsCanada @IASLC
2
17
58
4,642
Lung cancer awareness IS women’s health awareness
1
58
2
115
14,470
If you come train in thoracic surgery @MThoracics or want to do thoracic oncology research with our team @RIMUHC1, it’s worth noting that there is an excellent BBQ training component to the program! Please consider applying or reach out to our new program director @RousseauMC!
7
6
45
3,635
Joseph Seitlinger retweeted
The NADIM study will forever be remembered as one of the landmark lung cancer studies of the 21st century. I trust medical historians will remember it correctly and not rename it as the NADIM-I study. @DoctorJSpicer @FordePatrick
5
2
12
1,937
Are you a fellow or junior faculty specializing in thoracic surgery, med onc, rad onc, pathology or pulmonary med? Do you want to expand your horizons in translational thoracic oncology research?!? We have a fantastic funded opportunity for you as a post-doc @cusm_muhc @RIMUHC1 @McGillGCI Exceptional opportunity for multi-D collaborative research in various domains and with access to large scale multi-tier data sets.
17
36
3,928
Joseph Seitlinger retweeted
What great work from a couple of our previous @MThoracics fellows and @mcgill super student @LyndonCWalsh. They definitely didn’t learn this innovative technique from me!
2
7
912
Lung cancer is curable if caught early & LUNG CANCER SCREENING is SAFE and SAVES LIVES. @JVelottaMD @DavidCookeMD @AmLungCSI @ChiFuJeffYang @BTongMD @TomVargheseJr @BrendonStilesMD @hari_keshava @nchudgar @sands_jacob @atscommunity @AmericanCancer @LungRescue
If you wanted to tweet the same thing everyday for a month to drive home an education point from your specialty, what would it be?
19
1
38
7,596
Joseph Seitlinger retweeted
I would add, we’re so focused on drugs and surgery sometimes we forget how much of a difference simple things can make in a persons life. Exercise and nutrition are not life style modification they are medicine
4
9
976
Hey Twitter, The Thoracic Surgery Department is actively seeking a thoracic surgical resident for 6 months up to 1 year starting November 1st 2024. Annualy we perform over 950 cases. Futhermore, we are at the forefront of adopting novel minimally invasive and robotic approaches
2
1
4
1,035
Are you a general or thoracic surgeon looking to develop your skills with a world-class team of thoracic surgeons? Please consider submitting an application to our fellowship program by September 1st, 2024 for positions starting July 2025 and January 2026! mcgill.ca/thoracic/fellowshi… @MThoracics @mcgillsurgery
3
12
2
42
9,192
Anis Bouvard, candidat RN dans la 2e circonscription de Haute-Savoie... C'est du lourd 😅
544
1,358
687
4,224
1,586,293
Joseph Seitlinger retweeted
Online Now: Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial dlvr.it/T8YhfC
1
12
2
48
13,829
Joseph Seitlinger retweeted
The American Cancer Society publishes contemporary data on lung cancer screening rates in the US. 🇺🇸 jamanetwork.com/journals/jam…
3
14
1
36
8,062
What an absolute delight it was to welcome Dr. Najmeh, who made the journey all the way from Montreal to attend the French Thoracic and Cardiovascular Congress. Souvenir photo: our favourite McGill student, an incredible McGill associate professor and two McGill alumnis fellows.
3
1
11
1,803
Joseph Seitlinger retweeted
Great panel today in Nancy, France at the French Society of Cardiothoracic and Cardiovascular Surgery Annual Congress on advancements in thoracic immunotherapy. Interesting international discussion from @MThoracics’ Dr. @sara_najmeh & McGill alumni Dr. @JoSeitlinger! @mcgillu
3
9
785
Joseph Seitlinger retweeted
Neoadjuvant chemo-immunotherapy is superior to neoadjuvant chemotherapy across surgical, pathological and efficacy outcomes for patients with resectable NSCLC and improves EFS in patients with tumor PD-L1 <1%. @sorin_mark @DoctorJSpicer ja.ma/4dC49Ex
1
16
50
7,595